Increased Dopamine Content in Lymphocytes from High-Dose L-Dopa-Treated Parkinson’s Disease Patients

Publisher： Karger

E-ISSN： 1423-0216|12|2|81-84

ISSN： 1021-7401

Source： Neuroimmunomodulation, Vol.12, Iss.2, 2005-03, pp. : 81-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Light Symptoms following a High-Dose Intentional L-Thyroxine Ingestion Treated with Cholestyramine

By  

Hormone Research in Paediatrics, Vol. 57, Iss. 1-2, 2002-04 ,pp. : 61-63

Karger

Access to resources Recommend Favorite

Moderate Deterioration in Glucose Tolerance during High-Dose Growth Hormone Therapy in Glucocorticoid-Treated Patients with Juvenile Idiopathic Arthritis

By  

Hormone Research in Paediatrics, Vol. 73, Iss. 6, 2010-04 ,pp. : 465-472

Karger

Access to resources Recommend Favorite

Serum Uric Acid in Patients with Parkinson’s Disease and Vascular Parkinsonism: A Cross-Sectional Study

By  

Neuroimmunomodulation, Vol. 20, Iss. 1, 2012-11 ,pp. : 19-28

Karger

Access to resources Recommend Favorite

Serum Levels of Chemokines in Parkinson’s Disease

By  

Neuroimmunomodulation, Vol. 18, Iss. 4, 2011-03 ,pp. : 240-244

Karger

Access to resources Recommend Favorite

Influence of Age and Gender on Cytokine Expression in a Murine Model of Parkinson’s Disease

By  

Neuroimmunomodulation, Vol. 14, Iss. 5, 2008-01 ,pp. : 255-265

Karger

Access to resources Recommend Favorite